Home
About us
Reports
Charts
News
Custom
Company Scan
Report
Charts
News
*
Title
Content
Economy&Goods
Economy
ConsumerGoods
Food&Beverage
Agriculture
Life Sciences
Biotechnology
Medical
Pharmaceutical
Manufacturing
Automotive
Chemical
Energy
Machinery
Material
Metals & Minerals
Public Sector
Environment
Finance Service
Infrastructure
Logistics
Real Estate
Retailing
Tourism
Training
Technology And Media
Electronics
Internet
Hardware
Media
Software
Telecommunications
Tel:
0086-10-82600828
Fax:
0086-10-82601570
Email:
Home
>
News
>
Life Sciences
>
Biotechnology
Hualan Biological Engineering’s vaccine performance declined in 2011H1, blood product business expected to be favorable
CreateTime:2011-09-05 Source:ResearchInChina
Editor:hangmei
Text Size:
Related Company：
Hualan Biological Engineering Inc.(002007.SZ)
On 16 Aug. 2011, Hualan Biological released its semi-annual report, according to which, its operating revenue reached RMB470 million, a decline of 23.6% YoY; meanwhile, its net profit achieved RMB2...
UserName
PassWord
Validation Code
Remember Me Next Time
Forget password? get password
Welcome to our website.
This service is open to member only.
Contact our customer service team
Tel: 86-10-82600828, 82601561
Email: report@researchinchina.com
Related Reports
China Blood Product Industry Report, 2020-2026
China Vacuum Blood Collection Device Industry Report, 2019-2025
China Human Vaccine Industry Report, 2019-2025
China Independent Clinical Laboratory Industry Report, 2019-2025
Global and China Monoclonal Antibody Industry Report, 2019-2025
About RIC
|
Copyright
|
Contact Us
|
Privacy policy
|
Buy Reports
|
Member Service
|
Mailing List
2005-2010 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1